The recent surge in innovative oral weight loss medications has significant implications for psychiatry and behavioral medicine, particularly in Dr. Steven Locke’s practice. With the introduction of drugs such as semaglutide (Wegovy), tirzepatide (Zepbound), and promising candidates like ARD-101, healthcare providers are now equipped with more tools to assist patients struggling with obesity—a condition often …
SCHEDULE A CONSULTATION
During the time of Coronavirus social distancing, I am using a secure telehealth method for appointments. Also, during this Coronavirus emergency, many states are allowing their residents to be treated, via telepsychiatry, by psychiatrists who are licensed elsewhere. If you would like to work with me, please don’t hesitate to contact my office.